Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffd5528fd07384d7b07ab484ed5b143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faafbacd692f8f584c47fcca402df63a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15182151845c4143cd6462af5454df0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84209b81062d25a3f538c33f8e2c8edc |
publicationDate |
2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017189647-A1 |
titleOfInvention |
Methods and compositions for the treatment of myelodysplastic syndrome |
abstract |
The present invention provides methods and compositions for the treatment and prevention of myelodysplastic syndrome (MDS), and for the prevention of acute myeloid leukemia (AML) in MDS patients. In some embodiments such methods comprise administration of active agents that are Wnt/βcatenin pathway inhibitors. In some such methods delivery of such active agents is targeted to bone marrow stromal cells. Some such methods also involve first determining whether a subject is a candidate for treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023114888-A1 |
priorityDate |
2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |